Experts Say FDA Ignored Evidence In High-Dose Aricept Review
A pair of Dartmouth Medical School professors criticized the U.S. Food and Drug Administration for approving a 23-milligram dose of Pfizer Inc.'s Alzheimer's drug Aricept, saying in a Thursday article in...To view the full article, register now.
Already a subscriber? Click here to view full article